Join the Oncology Voice Network. Join for Free
All About Thought Leader Liaison
Thought Leader Engagement Pharma Industry Key Opinion Leaders Strategic Relationships Healthcare Professionals

All About Thought Leader Liaison


Share This Article


Summary

This weeks guest is Jim Hahn, Senior Business Director, Thought Leader Engagement at EMD Serono who discusses the role of the Thought Leader Liaison and how it fits into the pharma world.

Key Points

  • Thought leader liaisons (TLLs) focus on building deep, strategic relationships with key opinion leaders (KOLs) to align commercial objectives with the needs of healthcare providers.
  • TLLs typically come from successful sales backgrounds and do not require advanced scientific degrees, but must have strong interpersonal skills and a thorough understanding of their therapeutic area.
  • Effective communication between TLLs, MSLs, and sales reps is crucial to ensure seamless interactions with healthcare professionals and to avoid conflicts over access and time.

This weeks guest is Jim Hahn, Senior Business Director, Thought Leader Engagement at EMD Serono who discusses the role of the Thought Leader Liaison and how it fits into the pharma world.

Click for Source
Thought Leader Engagement, Pharma Industry, Key Opinion Leaders, Strategic Relationships, Healthcare Professionals

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Podcast
How Should Medical Affairs Engage on Social Media
Partner Avatar MSL Talk: Tom Caravela

How Should Medical Affairs Engage on Social Media

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN